Bladder Cancer: References

Figueroa JD, Koutros S, Colt JS, et al. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. J Natl Cancer Inst. 2015 Sep 14;107(11).

Patafio FM, Robert Siemens D, Wei X, Booth CM. Is there a gender effect in bladder cancer? A population-based study of practice and outcomes. Can Urol Assoc J. 2015 Jul-Aug;9(7-8):269-74.

Goossens ME, Buntinx F, Zeegers MP. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol. 2015 Aug 10.

Scarpato KR, Morgans AK, Moses KA. Optimal management of muscle-invasive bladder cancer - a review. Res Rep Urol. 2015 Sep 4;7:143-51.

Fakhrejahani F, Tomita Y, Maj-Hes A, et al. Immunotherapies for bladder cancer: a new hope. Curr Opin Urol. 2015 Sep 12.

Grubmueller B, Rouprêt M, Briganti A, Shariat SF. The use of biomarkers for bladder cancer diagnosis and surveillance. Mini Rev Med Chem. 2015 Sep 9.

Dobruch J, Daneshmand S, Fisch M, et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2015 Sep 4.

Alimohamed NS, Sridhar SS. Options in metastatic urothelial cancer after first-line therapy. Curr Opin Support Palliat Care. 2015 Sep;9(3):255-60.

Bladder Cancer. American Cancer Society Review. October 2014. http://www.cancer.org/acs/groups/cid/documents/webcontent/003085-pdf.pdf.

Bladder Cancer. National Cancer Institute, NCI Cancer topics PDQ. Accessed October 4, 2014. https://www.cancer.gov/cancertopics/pdq/treatment/bladder/Patient/page1.

Bladder Cancer. U.S. National Library of Medicine, PubMed. Accessed November 12, 2012. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001517/.

Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011 Aug 17;306(7):737-45.

Carradori S, Cristini C, Secci D, Gulia C, Gentile V, Di Pierro GB. Current and emerging strategies in bladder cancer. Anticancer Agents Med Chem. 2011 Oct 25.